Recombinant vascular endothelial cell growth factor d (vegf-d)
CA 2263890 C · Owner: Helsinki University Licensing Ltd. Oy · Inventors: Alitalo, Kari; Stacker, Steven A.; Achen, Marc G.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
VEGF-D, a new member of the PDGF family of growth factors which among other , things stimulates endothelial cell proliferation and angiogenesis and increases vascular permeability, is described as well as nucleotide sequences , encoding it methods for producing it, antibodies and other antagonists to it transfected or transformed host cells for expressing it pharmaceutical , compositions containing it and uses thereof in medical and diagnostic applications.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 21, 1997 and granted May 14, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 21, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.